Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stephen LaFon"'
Autor:
Robert T. Schooley, Michael S. Saag, William Spreen, Anders Sönnerborg, Brian Gazzard, Stephen LaFon, Danny Lancaster, Dennis Kelleher, Ramon A. Torres, Carmen Romero
Publikováno v:
AIDS. 12:F203-F209
Objectives: To evaluate, over 12 weeks, the antiretroviral activity and safety of abacavir, used alone and in combination with zidovudine (ZDV), as treatment for HIV-1-infected subjects who had limited or no antiretroviral treatment. Design: Seventy-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de046aaa7ee8376b6a74329938f854ca
https://doi.org/10.1097/00002030-199816000-00002
https://doi.org/10.1097/00002030-199816000-00002
Autor:
Judith Falloon, Joseph Kovacs, Walter Hughes, Donna O'Neill, Michael Polis, Richard T. Davey, Michael Rogers, Stephen LaFon, Irwin Feuerstein, Danny Lancaster, Mack Land, Carmelita Tuazon, Michael Dohn, Stephen Greenberg, H. Clifford Lane, Henry Masur
Publikováno v:
Scopus-Elsevier
The drug 566C80 is an investigational hydroxynaphthoquinone that is active against Pneumocystis carinii in vitro and in animal models. Initial studies in humans indicate that 566C80 is safe and has adequate bioavailability after oral administration.W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5532449b2b2d9f2209ed2021e7b159e7
https://doi.org/10.1056/nejm199111283252202
https://doi.org/10.1056/nejm199111283252202
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9:280
The clinical experience of human immunodeficiency virus (HIV) + patients treated with oral atovaquone for acute Pneumocytstis carinii pneumonia (PCP) under a Treatment Investigational New Drug (IND) protocol (mild or moderate PCP) and an Open-Label S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81703310f5251607572f87b392497de4
https://doi.org/10.1097/00042560-199507000-00009
https://doi.org/10.1097/00042560-199507000-00009